| |
N (%)
|
OR
|
95%CI
|
aOR
|
95%CI
|
|---|
|
CD4 (per mm3) (Screening Visit)
|
|
≥ 500 (ref)
|
111 (47.2)
|
1
|
–
|
1
|
–
|
|
350–499
|
49 (20.9
|
1.43
|
0.73–2.81
|
1.46
|
0.67–3.15
|
|
200–349
|
39 (16.6)
|
1.64
|
0.78–3.42
|
1.56
|
0.69–3.51
|
|
< 200
|
23 (9.8)
|
2.37
|
0.93–6.05
|
2.48
|
0.84–7.35
|
|
Missing
|
13 (5.5)
|
1.08
|
0.34–3.44
|
2.19
|
0.57–8.41
|
|
ptrenda=
| |
0.04
|
0.06
|
|
Detectable HIV Viral Load (Screening Visit)
|
|
No (ref)
|
183 (77.9)
|
1
|
–
|
1
|
–
|
|
Yes
|
27 (11.5)
|
1.99
|
0.84–4.63
|
1.75
|
0.67–4.57
|
|
Missing
|
25 (10.6)
|
0.47
|
0.19–1.13
|
0.34
|
0.12–0.98
|
|
Age Group (years) (Screening Visit)
|
|
30–33 (ref)
|
54 (23.0)
|
1
|
–
|
1
|
–
|
|
34–36
|
53 (22.6)
|
1.5
|
0.70–3.23
|
1.74
|
0.74–4.08
|
|
37–42
|
63 (26.8)
|
1.1
|
0.52–2.25
|
0.80
|
0.34–1.83
|
|
43–54
|
65 (27.7)
|
2.0
|
0.97–4.21
|
2.26
|
1.01–5.05
|
|
ptrend=
| |
0.13
|
0.17
|
|
Follow-Up Time (Days)
|
|
197–490 (ref)
|
66 (28.1)
|
1
|
–
|
1
|
–
|
|
490–649
|
62 (26.4)
|
0.38
|
0.29–0.79
|
0.35
|
0.16–0.77
|
|
650–820
|
49 (20.9)
|
0.89
|
0.43–1.86
|
0.94
|
0.41–2.14
|
|
821–1161
|
52 (22.1)
|
0.68
|
0.32–1.41
|
0.74
|
0.33–1.67
|
|
Missing
|
6 (2.6)
|
0.34
|
0.06–1.97
|
0.61
|
0.08–4.59
|
|
ptrenda=
| |
0.68
|
0.93
|
|
Colposcopic Impression
|
|
low-grade (ref)
|
207 (88.1)
|
1
|
–
|
1
|
–
|
|
high-grade
|
21 (8.9)
|
23.1
|
3.0–175.52
|
24.90
|
3.08–201.22
|
|
Missing
|
7 (3.0)
|
0.86
|
0.66–1.14
|
0.33
|
0.05–2.11
|
|
Number of hrHPV Types Detected at the Screening Visit
|
|
1 (ref)
|
133 (56.6)
|
1
|
–
| | |
|
≥ 2
|
102 (43.4)
|
0.99
|
0.59–1.66
| | |
- amissing values excluded from tests of trend, OR unadjusted odds ratio, aOR adjusted odds ratio and 95%CI 95% confidence interval
